Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Investigation

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI117965PMID 7539458PMCID PMC295946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the human BCL‐2 transgene increases the radiation resistance of a hematopoietic progenitor cell line

  1994cited by this paper
• Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death.

  1994cited by this paper
• Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase

  1994cited by this paper
• Bcl-2 and the regulation of programmed cell death

  1994cited by this paper
• Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.

  1994cited by this paper
• Fas ligation triggers apoptosis in macrophages but not endothelial cells

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis

  1994cited by this paper
• Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

  1994cited by this paper
• Transforming growth factor‐β2 induces apoptosis of murine T cell clones without down‐regulating bcl‐2 mRNA expression

  1994cited by this paper
• No requirement of reactive oxygen intermediates in Fas‐mediated apoptosis

  1994cited by this paper
• Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.

  1994cited by this paper
• bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS.

  1994cited by this paper
• The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis

  1994cited by this paper
• Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation.

  1994cited by this paper
• Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.

  1994cited by this paper
• Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

  1994cited by this paper
• Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction of bcl-2 Gene Expression

  1994cited by this paper
• Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway?

  1994cited by this paper
• Bcl-2 inhibits T-cell-mediated cytolysis of a leukemia cell line.

  1994cited by this paper
• Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways.

  1994cited by this paper
• Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma.

  1994cited by this paper
• APO‐1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl‐2 oncogene expression

  1993cited by this paper
• Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.

  1993cited by this paper
• bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.

  1993cited by this paper
• Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

  1993cited by this paper
• Effect of bcl-2 on Fas antigen-mediated cell death.

  1993cited by this paper
• Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

  1993cited by this paper
• Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity.

  1993cited by this paper
• Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.

  1993cited by this paper
• Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

  1993cited by this paper
• Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.

  1993cited by this paper
• Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.

  1993cited by this paper
• Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.

  1993cited by this paper
• Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme

  1993cited by this paper
• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  1993cited by this paper
• bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.

  1993cited by this paper
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

  1993cited by this paper
• Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents

  1992cited by this paper
• Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

  1992cited by this paper
• DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.

  1992cited by this paper
• bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.

  1992cited by this paper
• Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.

  1992cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

  1992cited by this paper
• Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma.

  1992cited by this paper
• Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing.

  1992cited by this paper
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo.

  1992cited by this paper
• Clinical effect of intra-arterial tumor necrosis factor-α for malignant glioma

  1992cited by this paper
• Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

  1991cited by this paper
• bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

  1991cited by this paper
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

  1991cited by this paper
• bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.

  1991cited by this paper
• The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

  1991cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• Monoclonal antibody-mediated tumor regression by induction of apoptosis.

  1989cited by this paper
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

  1989cited by this paper
• In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.

  1988cited by this paper
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

  1988cited by this paper
• T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.

  1987cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells

  1987cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

  1987cited by this paper
• Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family.

  1987cited by this paper
• Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

  1984cited by this paper

• NK and T cell evasion mechanism of human cytomegalovirus

  2025cites this paper
• Immune-cell signatures of persistent inflammation, immunosuppression, and catabolism syndrome after sepsis.

  2025cites this paper
• Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis

  2023cites this paper
• Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications

  2023cites this paper
• BAG1, MGMT, FOXO1, and DNAJA1 as potential drug targets for radiosensitizing cancer cell lines

  2022cites this paper
• Tumors and Cytomegalovirus: An Intimate Interplay

  2022cites this paper
• CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

  2022cites this paper
• Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation

  2021cites this paper
• The investigation of the role of Fas and FasL molecules in the extrinsic pathway of apoptosis as a target for cancer therapy in colorectal cancer

  2021cites this paper
• Cancer biology and other disorders: beneficial role of camptothecin and novel derivatives

  2020cites this paper
• Die Rolle von Arlts1 im Glioblastoma multiforme

  2020cites this paper
• Precision oncology : oncogenic stat3 signalling in brain tumours

  2019cites this paper
• The biochemical and molecular mechanisms involved in the role of micro-tumor environment stress in development of drug resistance.

  2019cites this paper
• Effect of nucleolin on adriamycin resistance via the regulation of B‐cell lymphoma 2 expression in Burkitt's lymphoma cells

  2019cites this paper
• Molecular Mechanisms of Phytochemical Actions in Cancer

  2019cites this paper
• Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells

  2018cites this paper
• In Search of a Breakthrough Therapy for Glioblastoma Multiforme

  2018cites this paper
• MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy

  2018cites this paper
• All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation

  2016cites this paper
• Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis

  2016cites this paper
• Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer

  2016cites this paper
• Targeting Cell Survival Proteins for Cancer Cell Death

  2016cites this paper
• Erratum: Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis

  2016cites this paper
• Thiosemicarbazones Target Multiple Resistance Pathways in Cancer

  2016cites this paper
• Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer

  2015cites this paper
• Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells.

  2015cites this paper
• Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.

  2014cites this paper
• Antiproliferative effects of Plumbago rosea and its purified constituent plumbagin on SK-MEL 28 melanoma cell lines

  2014cites this paper
• BEX1 Promotes Imatinib-Induced Apoptosis by Binding to and Antagonizing BCL-2

  2014cites this paper
• Increased paired box transcription factor 8 has a survival function in Glioma

  2014cites this paper
• Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population

  2014cites this paper
• Indoleamine 2,3-dioxygenase confers resistance to chemotherapy and γ radiation to cancer cells, independent of direct immune involvement

  2014cites this paper
• BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma.

  2013cites this paper
• Chemoresistance in Glioma

  2013cites this paper
• Enhancing radiation therapy for patients with glioblastoma

  2013cites this paper
• New Advances on Disease Biomarkers and Molecular Targets in Biomedicine

  2013cites this paper
• Targeting the Bcl-2 family for cancer therapy

  2013cites this paper
• Responses: A Key Role in Brain Astrocyte Apoptotic or Inflammatory CD95 (Fas/Apo-1) as a Receptor Governing

  2013cites this paper
• Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance

  2013cites this paper
• Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells.

  2012cites this paper
• Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma.

  2012cites this paper
• WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721.

  2012cites this paper
• B-cell lymphoma-2 promotes malignant progression in glioma.

  2011cites this paper
• Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis

  2011cites this paper
• LY 294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI 3 K / Akt pathway

  2011cites this paper
• The molecular pathology of central neurocytomas.

  2011cites this paper
• ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients

  2011cites this paper
• Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.

  2011cites this paper
• Immunosuppression associée à l’enzyme interleukine-4 induced gene 1 (IL4I1) : régulation de l’expression dans les cellules humaines et rôle dans l’échappement tumoral à la réponse immune dans un modèle murin

  2011cites this paper
• LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway.

  2011cites this paper
• Towards Tailored Therapy of Glioblastoma Multiforme

  2011cites this paper
• Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape

  2011influential citation
• Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line

  2011cites this paper
• Bcl‐2 promotes malignant progression in a PDGF‐B‐dependent murine model of oligodendroglioma

  2011cites this paper
• B-Cell Lymphoma-2 Promotes Malignant Progression in Glioma

  2011cites this paper
• Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System

  2011cites this paper
• The Role of Mitochondria in Glioma Pathophysiology

  2010cites this paper
• Deregulated signalling networks in human brain tumours.

  2010cites this paper
• Analysis of 2 Antiapoptotic Factors in Gliomas

  2009cites this paper
• Corticorelinacetateinjectionsfor thetreatmentofperitumoral brainedema

  2009cites this paper
• Corticorelin acetate injections for the treatment of peritumoral brain edema

  2009cites this paper
• Inositol hexaphosphate induces apoptosis by coordinative modulation of P53, Bcl-2 and sequential activation of caspases in 7,12 dimethylbenz[a]anthracene exposed mouse epidermis.

  2008cites this paper
• Manganese Superoxide Dismutase Contributes to Cisplatin-Induced Cytotoxicity Rather than All- Trans Retinoic Acid-Dependent Chemoresistance

  2008cites this paper
• The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.

  2008cites this paper
• The role of immunoediting in lymphomas of immune-privileged sites

  2008cites this paper
• Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma

  2008cites this paper
• Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas

  2008cites this paper
• Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins

  2008cites this paper
• treatmentastrocytic glioma: genetics, biology, and paths to

  2008cites this paper
• Chemoresistance in gliomas

  2008cites this paper
• Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF‐1β expression

  2008cites this paper
• Co-Inhibition von epidermal growth factor receptor (EGFR) und insulin-like growth factor-I receptor (IGF-IR):

  2007cites this paper
• The Significance of Poly-Targeting in Apoptosis Induction by Alkylating Agents and Platinum Drugs

  2007cites this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007influential citation
• Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors.

  2007cites this paper
• Malignant astrocytic glioma : genetics , biology , and paths to treatment

  2007influential citation
• Advances in the Treatment of Brain Metastases

  2007cites this paper
• Histopathologic Diagnosis, Cell Cycle Parameters and Clinical Behavior of 90 Egyptian Brain Tumor Cases

  2007cites this paper
• Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007cites this paper
• Radiotherapy response in oral squamous carcinoma cell lines: Evaluation of apoptotic proteins as prognostic factors

  2007cites this paper
• Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors

  2006cites this paper
• Apoptosis Pathways and Chemotherapy

  2006cites this paper
• IFN-y Induces Cell Growth Inhibition by Fas-mediated Apoptosis: Requirement of STATI Protein for Up-Regulation of Fas and FasL Expression1

  2006cites this paper
• Identifikation von Stressresistenzgenen in hämatologischen Neoplasien in Mus musculus (Linnaeus, 1758)

  2006cites this paper
• pERK, pAkt and pBad: A Possible Role in Cell Proliferation and Sustained Cellular Survival During Tumorigenesis and Tumor Progression in ENU Induced Transplacental Glioma Rat Model

  2006cites this paper
• Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.

  2006cites this paper
• Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.

  2005cites this paper
• p53 protein and bcl-2 expression in glioblastomas. Pathological correlations in a comprehensive series.

  2005cites this paper
• Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies

  2005cites this paper
• Angiogenesis and apoptosis in glioma: Two arenas for promising new therapies

  2005cites this paper
• Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.

  2005cites this paper
• Pharmacodynamics of Doxorubicin in Human Bladder Tumors1

  2005cites this paper
• Changing picture of cellular drug resistance in human leukemia.

  2004cites this paper
• Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation

  2004cites this paper
• Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic Implications

  2004cites this paper
• Protein Expression of Fas, Fas Ligand, Bcl-2 and TGFβ2 and Correlation with Survival in Initial and Recurrent Human Gliomas

  2004cites this paper
• Apoptosis in cancer--implications for therapy.

  2004cites this paper
• Induction of Apoptosis in Glioma Cells by Molecules Released from Activated Macrophages

  2004cites this paper
• Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

  2004cites this paper